BioCentury | Mar 19, 2012
Clinical News
Technetium-99m-EC-G: SPA received
...Cell Point received an SPA from FDA for a Phase III trial to evaluate IV technetium-99m-EC-G...
...timeline for the trial start was not disclosed. Cell Point LLC , Centennial, Colo. Product: Technetium-99m-EC-G...
...Business: Diagnostic Molecular target: NA Description: Single photon emission computed tomography (SPECT) cancer imaging agent 99m-Tc-EC-G...
...timeline for the trial start was not disclosed. Cell Point LLC , Centennial, Colo. Product: Technetium-99m-EC-G...
...Business: Diagnostic Molecular target: NA Description: Single photon emission computed tomography (SPECT) cancer imaging agent 99m-Tc-EC-G...
